Antiviral monotherapy for hospitalised patients with COVID-19 is not enough
- PMID: 33031761
- PMCID: PMC7535876
- DOI: 10.1016/S0140-6736(20)32078-X
Antiviral monotherapy for hospitalised patients with COVID-19 is not enough
Comment on
-
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.Lancet. 2020 Oct 24;396(10259):1345-1352. doi: 10.1016/S0140-6736(20)32013-4. Epub 2020 Oct 5. Lancet. 2020. PMID: 33031764 Free PMC article. Clinical Trial.
References
-
- WHO WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19. July 4, 2020. https://www.who.int/news-room/detail/04-07-2020-who-discontinues-hydroxy...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical